cognitive impairment

3 total trials 1 recruiting

Filter these 3 trials by phase, country, sponsor and more.

Open in Search →

A phase 1, randomized, double-blind, placebo-controlled study investigating the safety, tolerability, pharmacokinetics, and pharmacodynamics … Not authorised

2024-512106-26-00 1
Longitudinal multicenter head-to-head harmonization of tau PET tracers (HEAD Study) Recruiting

2023-510508-31-01 4 2024-07-01
A phase 1, randomized, double-blind, placebo-controlled study investigating the safety, tolerability, pharmacokinetics, and pharmacodynamics … Ended

2024-512106-26-02 1 2024-11-19

Showing 1–3 of 3 trials